To Get Help Now
Click Here
 
Today's Date:

Glaxo Set To Settle More Avandia Lawsuits

AddThis Social Bookmark Button

GlaxoSmithKline Plc., is working to settle more than 1,000 lawsuits filed by former Avandia users in Pennsylvania, California and Illinois.  A lawyer for the plaintiffs said that there are “about 5,300 state-court cases pending” and that she expected many of them to be resolved.

Avandia , once the most sold diabetes drug in the world, was pulled from European markets and had limited use in the United States after researchers linked the drug to an increased risk of heart attack and stroke.

Over the last year, Glaxo has agreed to pay more than $700 million to resolve more than 12,000 lawsuits alleging failure to warn consumers of the risks of use. Glaxo has also updated the drugs warning label including safety restrictions.

Glaxo has already settled 2,400 claims in Los Angeles, and is expected to settle 200 claims in Philadelphia and more in Illinois.  Of the lawsuits that have not been settled, 1,600 have been consolidated in Philadelphia for pre-trial proceedings. California has a trial date for November and New Mexico has trial dates set for November and March.

Avandia has recently set aside more than $6 billion to cover legal costs and investigations for its diabetes drug, and other drugs like its antidepressant Paxil and its line of denture creams.

breakinglawsuitnews.com disclaimer: This article: Glaxo Set To Settle More Avandia Lawsuits was posted on Thursday, May 5th, 2011 at 8:08 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.